Fundz

Who to call at Adaptive Biotechnologies Corporation, and when

Fundz watches for the moments Adaptive Biotechnologies Corporation starts buying, and tells you who to reach.

  • An alert the day Adaptive Biotechnologies Corporation raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Adaptive Biotechnologies Corporation, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

LaunchAdaptive Biotechnologies Corporation presents clonoSEQ® MRD Testing at the 66th ASH Annual Meeting to showcase its effectiveness in blood cancer treatment.

Dec 03, 2024
SeattleBiotechnologyHealth CareTherapeutics

Product Description

Adaptive Biotechnologies Corporation announced that its clonoSEQ® test for measurable residual disease assessment will feature in over 65 abstracts at the 66th Annual Meeting of the ASH, highlighting its role in clinical decision-making and precision medicine.

Company Information

Company

Adaptive Biotechnologies Corporation

Location

Seattle, Washington, United States

About

Adaptive Biotechnologies is a commercial-stage biotechnology company focused on harnessing the adaptive immune system's biology to transform disease diagnosis and treatment. They develop clinical products aimed at diagnosing and treating diseases using advanced genetic techniques. Their flagship product, clonoSEQ®, is designed to detect minimal residual disease in various blood cancers. The company's innovative approach seeks to provide precise and effective solutions in the field of hematology.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Adaptive Biotechnologies Corporation ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Francis hidden

hidden
Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Adaptive Biotechnologies Corporation's next move

Learn about Strategic plan

Product Launch Insights

What this usually means
Market expansion signals
New product launches often coincide with market expansion initiatives

Adaptive Biotechnologies Corporation shipped something new. Fundz reads product launches, trademark filings and hiring together.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.